Solving Cell Therapy’s “Garbage in, Garbage out” Problem with Automation
Tony Ward
Despite industry’s emphasis on cell engineering and expansion, better starting materials are the foundation of the manufacturing revolution
Tony Ward
Tony Ward is chief technology officer at Curate Biosciences. Curate is developing its Cell Processing System, which applies microfluidics-based deterministic cell separation (DCS) technology for T cell isolation through a benchtop system and single-use cartridges. Tony was previously global strategic marketing director for Becton Dickinson’s research cell analysis business, headed commercial operations for eBioscience, and served as SVP/general manager for Affymetrix’s business unit.